Belantamab mafodotin (Blenrep)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Belantamab mafodotin (Blenrep), covering 2025-03-30 to 2025-11-12. Get the full timeline:
Most recent: Clinical Trial Update: Belantamab Mafadotin Maintenance Therapy After Salvage Autologous Hematopoietic Cell Transplantation in Patients With Relapse Refractory Multiple Myeloma [Phase 1]